Steven Cohen's FHTX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 27,646 shares of Foghorn Therapeutics Inc. (FHTX) worth $132,148, representing 0.00% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in FHTX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2021, adding 383,472 shares. Largest reduction occurred in Q1 2022, reducing 378,272 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Foghorn Therapeutics (FHTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Foghorn Therapeutics (FHTX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -34,322 | Reduce 55.39% | 27,646 | $4.78 |
| Q4 2025 | -309,065 | Reduce 83.30% | 61,968 | $5.40 |
| Q3 2025 | -297,686 | Reduce 44.52% | 371,033 | $4.89 |
| Q2 2025 | +43,502 | Add 6.96% | 668,719 | $4.70 |
| Q1 2025 | -9,544 | Reduce 1.50% | 625,217 | $3.65 |
| Q4 2024 | +235,059 | Add 58.81% | 634,761 | $4.72 |
| Q3 2024 | -6,939 | Reduce 1.71% | 399,702 | $9.31 |
| Q2 2024 | -30,728 | Reduce 7.03% | 406,641 | $5.75 |
| Q1 2024 | -102,631 | Reduce 19.01% | 437,369 | $6.71 |
| Q4 2023 | +255,145 | Add 89.57% | 540,000 | $6.45 |
| Q3 2023 | +5,700 | Add 2.04% | 284,855 | $5.00 |
| Q2 2023 | +279,155 | New Buy | 279,155 | $7.04 |
| Q1 2023 | -33,000 | Sold Out | 0 | $0.00 |
| Q4 2022 | -355,600 | Reduce 91.51% | 33,000 | $6.38 |
| Q3 2022 | +12,600 | Add 3.35% | 388,600 | $8.58 |
| Q2 2022 | +370,800 | Add 7130.77% | 376,000 | $13.60 |
| Q1 2022 | -378,272 | Reduce 98.64% | 5,200 | $15.19 |
| Q4 2021 | +383,472 | New Buy | 383,472 | $22.87 |
| Q2 2021 | -109,200 | Sold Out | 0 | $0.00 |
| Q1 2021 | +109,200 | New Buy | 109,200 | $13.18 |
Steven Cohen's Foghorn Therapeutics Investment FAQs
Steven Cohen first purchased Foghorn Therapeutics Inc. (FHTX) in Q1 2021, acquiring 109,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Foghorn Therapeutics Inc. (FHTX) for 20 quarters since Q1 2021.
Steven Cohen's largest addition to Foghorn Therapeutics Inc. (FHTX) was in Q4 2021, adding 383,472 shares worth $8.77 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 27,646 shares of Foghorn Therapeutics Inc. (FHTX), valued at approximately $132,148.
As of the Q1 2026 filing, Foghorn Therapeutics Inc. (FHTX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Foghorn Therapeutics Inc. (FHTX) was 668,719 shares, as reported at the end of Q2 2025.